He, Zhaoxuan
Yang, Yi
Wen, Qiao
Yin, Tao
Li, Zhengjie
Ma, Peihong
Zheng, Hui
Yang, Yunhong
Jiang, Yongliang
Fang, Jianqiao
Lan, Lei
Zeng, Fang
Funding for this research was provided by:
the National Key Research and Development Program (2018YFC1704605)
the National Key Research and Development Program (2018YFC1704600)
Article History
Received: 23 December 2019
Accepted: 22 October 2020
First Online: 6 November 2020
Ethics approval and consent to participate
: This trial has been approved by the Sichuan Regional Ethics Review Committee on Traditional Chinese Medicine (Approval number: 2019KL-026). This trial follows the principles of the Declaration of Helsinki (Version Edinburgh 2000).All eligible patients will be informed of the study’s details and all the benefits and risks that they may take from this trial. Patients will be asked if they agree to use their data on the consent form should they choose to withdraw from the trial. Patients will also be asked for permission for the research team to share relevant data with people from the universities taking part in the research or from regulatory authorities. In addition, all researchers were trained and signed a pledge to protect the confidentiality of study participants.
: Study results will be published by the investigators in peer-reviewed journals or presented at conferences.
: The authors declare that they have no competing interests.